Sandercock Colin - Net Worth and Insider Trading
Sandercock Colin Net Worth
The estimated net worth of Sandercock Colin is at least $28,941 dollars as of 2024-11-13. Sandercock Colin is the SVP, General Counsel and Sec of Cue Biopharma Inc and owns about 17,125 shares of Cue Biopharma Inc (CUE) stock worth over $28,941. Details can be seen in Sandercock Colin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sandercock Colin has not made any transactions after 2020-08-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sandercock Colin
Sandercock Colin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sandercock Colin owns 1 companies in total, including Cue Biopharma Inc (CUE) .
Click here to see the complete history of Sandercock Colin’s form 4 insider trades.
Insider Ownership Summary of Sandercock Colin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CUE | Cue Biopharma Inc | 2021-02-10 | SVP & General Counsel and Sec |
Sandercock Colin Latest Holdings Summary
Sandercock Colin currently owns a total of 1 stock. Sandercock Colin owns 17,125 shares of Cue Biopharma Inc (CUE) as of August 5, 2020, with a value of $28,941.
Latest Holdings of Sandercock Colin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CUE | Cue Biopharma Inc | 2020-08-05 | 17,125 | 1.69 | 28,941 |
Holding Weightings of Sandercock Colin
Sandercock Colin Form 4 Trading Tracker
According to the SEC Form 4 filings, Sandercock Colin has made a total of 3 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Cue Biopharma Inc is the sale of 13,274 shares on August 5, 2020, which brought Sandercock Colin around $265,480.
Insider Trading History of Sandercock Colin
- 1
Sandercock Colin Trading Performance
GuruFocus tracks the stock performance after each of Sandercock Colin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sandercock Colin is -0.24%. GuruFocus also compares Sandercock Colin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sandercock Colin within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sandercock Colin's insider trading performs compared to the benchmark.
Performance of Sandercock Colin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.35 | | | | | |
| Relative Return to S&P 500(%) | -18.03 | | | | | |
Sandercock Colin Ownership Network
Ownership Network List of Sandercock Colin
Ownership Network Relation of Sandercock Colin
Sandercock Colin Owned Company Details
What does Cue Biopharma Inc do?
Who are the key executives at Cue Biopharma Inc?
Sandercock Colin is the SVP & General Counsel and Sec of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , director & CEO Daniel R Passeri , and Chief Medical Officer Matteo Levisetti .
Cue Biopharma Inc (CUE) Insider Trades Summary
Over the past 18 months, Sandercock Colin made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net purchase of 4,000 shares made by Anish Suri , and a net purchase of 3,000 shares made by Daniel R Passeri .
In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net purchase of 7,000 shares.
Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cue Biopharma Inc Insider Transactions
Sandercock Colin Mailing Address
Above is the net worth, insider trading, and ownership report for Sandercock Colin. You might contact Sandercock Colin via mailing address: 40 Guest Street, Boston Ma 02135.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
